CAPR

Capricor Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

32.9%

Short % Float

2.1d to cover · Moderate squeeze

68.0%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

7.2% of float

48.5M sh

Public Float

49/100

Dilution Score

Medium

68 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

49/100

MEDIUM

Inst: 67.95% · Top: Blackrock Inc.

Biotech Analytics

Biotech / Pharma

48.69

Squeeze risk: MODERATEBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk49

Clinical Trials0

Short Interest90